STOCK TITAN

The Pennant Group Appoints Brent Guerisoli as Chairman and Scott Lamb as Lead Independent Director

(Neutral)
(Very Positive)
Tags
management

The Pennant Group (NASDAQ: PNTG) has announced key leadership changes to its board of directors, effective January 1, 2025. Brent Guerisoli, the company's current CEO since 2022, has been appointed as Chairman of the board, succeeding Barry Smith who will remain on the board and continue as chairman of the nominating and corporate governance committee.

Additionally, Scott Lamb has been appointed as Lead Independent Director. Lamb, who has served on Pennant's board and as chairman of its audit committee since 2019, brings valuable experience from his previous role as CFO of ICU Medical (2008-2020). Guerisoli, who has been with the organization since 2012 and joined the board in 2023, has been recognized for his inspiring leadership, consistent performance, and transparent communication.

Loading...
Loading translation...

Positive

  • CEO Brent Guerisoli's promotion to Chairman indicates strong board confidence in current leadership
  • Appointment of experienced former CFO Scott Lamb as Lead Independent Director strengthens corporate governance
  • Continuity maintained with Barry Smith remaining on the board

Negative

  • None.

News Market Reaction – PNTG

+0.30%
+0.30% Session move

In the trading session that priced this news, PNTG gained 0.30%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

EAGLE, Idaho, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, and senior living companies, today announced the appointment of Brent Guerisoli as Chairman of its board of directors and Scott Lamb as Lead Independent Director of its board of directors, each effective January 1, 2025. Mr. Guerisoli and Mr. Lamb are existing directors of the Company.

Mr. Guerisoli has served on Pennant’s board since 2023. He has been a key leader with the organization since 2012 and has served as its Chief Executive Officer since 2022. Mr. Guerisoli succeeds Barry Smith, who served as Chairman since February 2023. Mr. Smith will remain on the Company’s board and will continue to serve as chairman of the nominating and corporate governance committee of the board.

“The board has great confidence in Brent,” said Mr. Smith, “which he has earned through his inspiring leadership, consistent performance, and transparent communication. He will make an excellent Chairman to lead Pennant forward.”

Also effective January 1, 2025, the board has appointed Mr. Lamb as the Company’s Lead Independent Director. Mr. Lamb has served on Pennant’s board and as chairman of its audit committee since 2019. Mr. Lamb served as Chief Financial Officer of publicly traded medical device company ICU Medical, Inc. from 2008 to 2020, which provided invaluable experience and perspective that he draws on when carrying out his current board duties.

“Scott is a capable leader with a strong and respected voice on the board, which makes him an exemplary choice to serve as Lead Independent Director,” remarked Mr. Smith. “We know that under his leadership and coordination, the independent directors will be robust participants with appropriately significant influence on board decisions.”

About Pennant:

The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through 122 home health and hospice agencies and 57 senior living communities located throughout Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. Each of these businesses is operated by a separate, independent operating subsidiary that has its own management, employees and assets. References herein to the consolidated "company" and "its" assets and activities, as well as the use of the terms "we," "us," "its" and similar verbiage, are not meant to imply that The Pennant Group, Inc. has direct operating assets, employees or revenue, or that any of the home health and hospice businesses, senior living communities or the Service Center are operated by the same entity. More information about Pennant is available at www.pennantgroup.com.

Contact Information

The Pennant Group, Inc.
(208) 506-6100
ir@pennantgroup.com

SOURCE: The Pennant Group, Inc.


FAQ

When will Brent Guerisoli assume his role as Chairman of PNTG?

Brent Guerisoli assumed his role as Chairman of The Pennant Group (PNTG) effective January 1, 2025.

Who did Brent Guerisoli replace as Chairman of PNTG?

Brent Guerisoli replaced Barry Smith, who served as Chairman since February 2023. Smith will remain on the Company's board and continue as chairman of the nominating and corporate governance committee.

What is Scott Lamb's background before becoming PNTG's Lead Independent Director?

Scott Lamb served as Chief Financial Officer of ICU Medical from 2008 to 2020, and has been serving on Pennant's board and as chairman of its audit committee since 2019.

How long has Brent Guerisoli been with The Pennant Group?

Brent Guerisoli has been with The Pennant Group since 2012, serving as CEO since 2022 and on the board since 2023.